GTC Biotherapeutics (fka GTCB)

[n4807g]

Thanks for the transcript. To me this is the "keystone" to unlock the value of GTC. I hope that any US partner acknowledges the competitive advantage GTC enjoys and suggests other opportunities will be explored. What GTC needs is recognition by the investing community that they can be the Henry Ford of "chemical entity" production.

"It is the size of the markets for the portfolio products which are largely known chemical entities and which leverage the same production platform and infrastructure as ATryn. The uniqueness of our production technology provides a competitive advantage with these products by enabling us to produce large volumes of products at attractively competitive manufacturing costs and capital investment."

Going forward in time this country (and the world) will need lower cost drugs. When the investing community recognizes that GTC is positioned to make lower cost compounds this company will become a share price winner.